Pages
Products

Panoply™ Human TNFSF15 Knockdown Stable Cell Line

For research use only. Not intended for any clinical use.

Cat. No. :   CSC-DC016378

Host Cell :   HEK293 (Hela and other cell types are also available) Validation :   Real-Time RCR

Inquire for Price

Cell Line Information

Safety and Packaging

Gene Information

Cat. No. CSC-DC016378
Description Creative Biogene's Knockdown Cell Lines are target specific shRNA lentivirus transduced cells. The percent knockdown levels range from 75-99% depending on the gene, as evaluated by Real-Time RCR. Cells are rigorously qualified and mycoplasma free.
Target Gene TNFSF15
Host Cell HEK293 (Hela and other cell types are also available)
Host Cell Species Homo sapiens (Human)
Applications

(1) Studying gene functions

(2) Studying gene interactions and signaling pathways

(3) Target validation and drug discovery

(4) Designing diseases models

Size >1 × 106 cells / vial
Stability Validated for at least 10 passages
Validation Real-Time RCR
Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Storage Liquid Nitrogen
Shipping Dry Ice
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations The following safety precautions should be observed.
1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.
2. No eating, drinking or smoking while handling the stable line.
3. Wash hands after handling the stable line and before leaving the lab.
4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.
5. All waste should be considered hazardous.
6. Dispose of all liquid waste after each experiment and treat with bleach.
Ship Dry ice
Gene Name TNFSF15 tumor necrosis factor (ligand) superfamily, member 15 [ Homo sapiens ]
Gene Symbol TNFSF15
Synonyms TL1; TL1A; VEGI; VEGI192A
GeneID 9966
Uni ProtID O95150
mRNA Refseq NM_001204344.1
Protein Refseq NP_001191273.1
Chromosome Location 9q32
Function cytokine activity; death receptor binding; receptor binding; tumor necrosis factor receptor binding;
Pathway Cytokine-cytokine receptor interaction, organism-specific biosystem; Cytokine-cytokine receptor interaction, conserved biosystem; Senescence and Autophagy, organism-specific biosystem;
MIM 604052
Quick Inquiry

Case Study

Q & A

Customer Reviews

Metastasis is a major challenge in colorectal cancer (CRC) and a key factor contributing to its high mortality rate. Tumor necrosis factor (TNF)-like cytokine 1A (TL1A, also known as TNFSF15) is a novel regulator of inflammatory diseases. Here, researchers investigated the role of TL1A in CRC metastasis. The results demonstrated that in an azoxymethane/dextran sulfate sodium (AOM/DSS)-induced mouse model, TL1A knockdown significantly inhibited colon tumor formation, as well as the in vivo growth and pulmonary and hepatic metastasis of CRC cells. Loss of TL1A reduced the inflammatory response and inflammatory cell infiltration at tumor sites. In vitro experiments showed that TL1A knockdown suppressed CRC cell growth and metastasis and altered the expression of epithelial-mesenchymal transition (EMT)-related biomarkers. TL1A deficiency reduced TGF-β1 receptor (TβRI) levels and Smad3 phosphorylation in CRC cells. TGF-β stimulation restored the migration and invasion capabilities of CRC cells that had been suppressed by shTL1A. These findings indicate that TL1A promotes CRC tumorigenesis and metastasis and confirm that the TGF-β/Smad3 signaling pathway mediates TL1A-induced regulation of CRC cell metastasis.

In this study, researchers investigated the in vitro effects of TL1A on colorectal cancer (CRC) cells. First, compared to the normal FHC cell line, TL1A expression was observed to be significantly elevated across multiple CRC cell lines (including SW480, LoVo, SW620, RKO, and HCT116) (Figure 1A); SW480 and HCT116 cells exhibited the highest expression levels and were consequently selected for subsequent knockdown experiments. The researchers then generated TL1A-knockdown SW480 and HCT116 cell lines (Figure 1B). To explore the role of TL1A in CRC cell proliferation and metastasis, they conducted CCK-8, EdU staining, and Transwell assays. The results demonstrated that, compared to the control group, proliferation was significantly inhibited in TL1A-knockdown cells (Figure 1C and D), and the number of CRC cells undergoing migration and invasion was reduced (Figure 1E). Furthermore, TL1A knockdown led to increased E-cadherin levels and decreased Vimentin levels, further indicating that the loss of TL1A suppresses the metastatic potential of CRC cells.

Figure 1. TL1A depletion suppressed the in vitro growth and metastasis of CRC cells.Figure 1. TL1A depletion suppressed the in vitro growth and metastasis of CRC cells. (Niu W, et al., 2024)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction